Easton Pharmaceuticals (Easton Pharmaceuticals) Total Stockholders Equity : $6.65 Mil (As of Sep. 2021)

View and export this data going back to . Start your Free Trial

What is Easton Pharmaceuticals Total Stockholders Equity?

Easton Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Sep. 2021 was $6.65 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Easton Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2021 was $0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Easton Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2021 was 0.43.

Easton Pharmaceuticals Total Stockholders Equity Historical Data

The historical data trend for Easton Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easton Pharmaceuticals Total Stockholders Equity Chart

Easton Pharmaceuticals Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec18

Dec19

Dec20

Total Stockholders Equity

Get a 7-Day Free Trial

-0.10

0.13

7.14

7.10

6.91

Easton Pharmaceuticals Quarterly Data
	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21
Total Stockholders Equity	Get a 7-Day Free Trial															7.10	6.91	6.81	6.73	6.65

Easton Pharmaceuticals (OTCPK:EAPH) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Easton Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2021 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(6.647	-	0)	/	1344.93
	=	0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Easton Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2021 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	2.837)	/	6.647
	=	0.43

Easton Pharmaceuticals Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Easton Pharmaceuticals's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Easton Pharmaceuticals (Easton Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Easton Pharmaceuticals Inc (OTCPK:EAPH) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Bloor Street East, Suite 3500, Toronto, ON, CAN, M4W 1A8

Website

http://www.eastonpharmaceuticalsinc.com

Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.